LDX Insider Trading (Lumos Diagnostics)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00
Lumos Diagnostics Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/29/2021 11:06 AM ET
Invest in Artificial Intelligence Before It Changes the World
From HiveSkill | Ad
A.I. is going to be one of the dominant themes over the next decade, as companies automate their businesses and use A.I. to remain competitive. This is the golden age of investing in artificial intelligence!
Invest in this red-hot industry at pre-IPO prices.
Lumos Diagnostics Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
10/28/2021 | Robert Sambursky | Insider | Issued | 24,000 | A$1.25 | A$30,000.00 | | |
The Last Great Value Stock
From Oxford Club | Ad
Last year it was more profitable than Disney, Square or even Tesla.
But it's just under $2 per share.
This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.
Check out the free presentation by clicking here.
>>>
SEC Filings (Institutional Ownership Changes) for Lumos Diagnostics (ASX:LDX)
Lumos Diagnostics Holdings Limited operates as an integrated developer and manufacturer of point-of-care (POC) diagnostic tests. The company develops and manufactures proprietary and in-licensed POC diagnostic tests. Its products include FebriDx, a test that differentiates between bacterial and viral respiratory infections; ViraDx, a combined COVID/Influenza test for acute respiratory infections; and CoviDx, an antigen test for COVID-19. The company also engages in the contract research and development services specialized in the innovation, development, commercialization, and manufacturing of point-of-care diagnostic solutions for clinical and consumer applications. It offers its products through distributors primarily in the North American and European markets. The company was founded in 2004 and is headquartered in Melbourne, Australia.
Read More on Lumos Diagnostics
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Lumos Diagnostics?